Valuation: Noritsu Koki Co., Ltd.

Capitalization 216B 1.37B 1.18B 1.1B 1.02B 1.9B 124B 2.05B 12.63B 4.98B 59.21B 5.13B 5.02B P/E ratio 2025 *
14.7x
P/E ratio 2026 * 13.5x
Enterprise value 216B 1.37B 1.18B 1.1B 1.02B 1.9B 124B 2.05B 12.63B 4.98B 59.21B 5.13B 5.02B EV / Sales 2025 *
1.85x
EV / Sales 2026 * 1.74x
Free-Float
50.39%
Yield 2025 *
3.64%
Yield 2026 * 3.65%
More valuation ratios * Estimated data
Dynamic Chart
Jan. 15 Noritsu Koki to Buy Building Materials Maker Senqcia for 69 Billion Yen MT
Jan. 14 Noritsu Koki Co., Ltd. entered into a definitive agreement to acquire Senqcia Corporation from Lone Star Fund XI, L.P., a fund managed by Lone Star Americas Acquisitions, Inc. for ¥69 billion. CI
Nov. 14 Noritsu Koki Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
Nov. 14 Noritsu Koki Co., Ltd. Revises Consolidated Earnings Guidance for Fiscal Year Ending December 31, 2025 CI
25-08-08 Noritsu Koki Co., Ltd. Provides Consolidated Earnings Guidance for Fiscal Year Ending December 31, 2025 CI
25-08-08 Noritsu Koki Co., Ltd. Announces Dividend for the Second Quarter-End of Fiscal Year Ending December 31, 2025, Payable on September 1, 2025 CI
25-06-24 Tranche Update on Noritsu Koki Co., Ltd.'s Equity Buyback Plan announced on March 4, 2025. CI
25-06-22 Noritsu Koki Co., Ltd.'s Equity Buyback announced on March 4, 2025, has closed with 460,700 shares, representing 1.29% for ¥1,999.64 million. CI
25-05-09 Noritsu Koki Co., Ltd. Revises Consolidated Earnings Guidance for Fiscal Year Ending December 31, 2025 CI
25-05-09 Noritsu Koki Co., Ltd. Provides Dividend Guidance for Second Quarter End and for Year End of Fiscal Year Ending December 31, 2025 CI
25-05-09 Noritsu Koki Co., Ltd. Revises Earnings Guidance for Half Year of Fiscal Year 2025 (January 1, 2025 to June 30, 2025) CI
25-04-04 Tranche Update on Noritsu Koki Co., Ltd.'s Equity Buyback Plan announced on March 4, 2025. CI
25-03-04 Noritsu Koki Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.4% for ¥2,000 million. CI
More news
1 day+2.84%
1 week+7.03%
Current month+9.05%
1 month+7.03%
3 months+19.47%
6 months+35.81%
Current year+9.05%
More quotes
1 week 1,873
Extreme 1873
2,073
1 month 1,828
Extreme 1828
2,073
Current year 1,828
Extreme 1828
2,073
1 year 1,206.67
Extreme 1206.6667
2,073
3 years 689.33
Extreme 689.3333
2,073
5 years 575
Extreme 575
2,073
10 years 123.33
Extreme 123.3333
2,073
More quotes
Manager TitleAgeSince
Chief Executive Officer 47 2018-05-31
Director of Finance/CFO - -
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member 53 2015-06-28
Director/Board Member 72 2015-05-31
Director/Board Member 74 2015-05-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.84%+7.03%+23.98%+160.62% 1.37B
-0.56%+4.33%+12.83%+27.14% 6.06B
-0.10%+1.22%+31.42%+11.69% 5.76B
-0.31%+10.01%+44.91%+1.60% 5.75B
+2.90%+2.90%+36.11%+12.30% 3.95B
-1.23%+0.92%+47.53%+41.03% 3.94B
+1.10%+7.56%+0.08%-20.00% 1.35B
+0.89%+7.41%-12.81%+30.48% 1.25B
-0.83%-2.05%+247.18%+240.36% 1.21B
Average +0.52%+3.76%+47.92%+56.13% 3.4B
Weighted average by Cap. +0.21%+4.10%+37.98%+31.77%
See all sector performances

Financials

2025 *2026 *
Net sales 117B 739M 637M 593M 552M 1.03B 67.09B 1.11B 6.83B 2.69B 32B 2.77B 2.72B 124B 788M 679M 632M 589M 1.1B 71.48B 1.18B 7.27B 2.87B 34.1B 2.95B 2.89B
Net income 14.65B 92.7M 79.92M 74.4M 69.26M 129M 8.41B 139M 856M 337M 4.01B 348M 340M 15.85B 100M 86.46M 80.49M 74.93M 140M 9.1B 150M 926M 365M 4.34B 376M 368M
Net Debt - -
More financial data * Estimated data
Logo Noritsu Koki Co., Ltd.
Noritsu Koki Co., Ltd. is a company principally engaged in the manufacturing business, healthcare business and other businesses. The Company operates in six business segments. The Manufacturing segment is engaged in the research, development and manufacture of pen nib parts and cosmetics materials, among others. The Healthcare segment is engaged in the research, development and sale of radiological business support services by remote diagnostic imaging in the healthcare area, the analysis of received data and the provision of survey data, among others. The Drug Discovery segment develops new products in biotechnology area. The Senior and Life segment conducts senior publishing and mail order sales business. The Agri-food segment conducts the production and sale of fresh vegetables in the agri-food field. The Others segment conducts new growth related survey and investment business.
Employees
1,239
More about the company
Date Price Change Volume
26-01-16 2,025.00 ¥ +2.84% 503,400
26-01-15 1,969.00 ¥ +0.31% 282,700
26-01-14 1,963.00 ¥ +4.19% 489,100
26-01-13 1,884.00 ¥ -0.42% 690,500
26-01-09 1,892.00 ¥ 0.00% 203,300

Delayed Quote Japan Exchange, January 16, 2026 at 01:30 am EST

More quotes
Trader
-
Investor
Global
-
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,025.00JPY
Average target price
2,600.00JPY
Spread / Average Target
+28.40%
Consensus

Quarterly revenue - Rate of surprise